| Zugriffe | |
|---|---|
| Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant | 112 |
| Juli 2025 | August 2025 | September 2025 | Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | |
|---|---|---|---|---|---|---|---|
| Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant | 3 | 13 | 11 | 13 | 14 | 6 | 7 |
| Zugriffe | |
|---|---|
| CPT Pharmacom Syst Pharma - 2024 - Kim - Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows.pdf | 68 |
